News | 28 May 2012
Sihuan Pharmaceutical Holdings' Roxatidine Acetate Hydrochloride for Injection has passed on-site inspection for drug registration conducted by the Chinese State Food and Drug Administration. The company anticipates the approval of production in the ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)